Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Editas Medicine (EDIT) Assets Average (2016 - 2025)

Historic Assets Average for Editas Medicine (EDIT) over the last 10 years, with Q3 2025 value amounting to $206.2 million.

  • Editas Medicine's Assets Average fell 4211.81% to $206.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $206.2 million, marking a year-over-year decrease of 4211.81%. This contributed to the annual value of $420.4 million for FY2024, which is 1704.36% down from last year.
  • According to the latest figures from Q3 2025, Editas Medicine's Assets Average is $206.2 million, which was down 4211.81% from $237.1 million recorded in Q2 2025.
  • Editas Medicine's Assets Average's 5-year high stood at $768.1 million during Q2 2021, with a 5-year trough of $206.2 million in Q3 2025.
  • For the 5-year period, Editas Medicine's Assets Average averaged around $502.4 million, with its median value being $503.0 million (2023).
  • In the last 5 years, Editas Medicine's Assets Average soared by 3867.01% in 2021 and then tumbled by 4252.75% in 2025.
  • Over the past 5 years, Editas Medicine's Assets Average (Quarter) stood at $697.3 million in 2021, then dropped by 25.04% to $522.7 million in 2022, then decreased by 3.97% to $501.9 million in 2023, then plummeted by 33.34% to $334.6 million in 2024, then plummeted by 38.38% to $206.2 million in 2025.
  • Its last three reported values are $206.2 million in Q3 2025, $237.1 million for Q2 2025, and $302.6 million during Q1 2025.